BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 27607458)

  • 1. The effect of renal denervation in moderate treatment-resistant hypertension with confirmed medication adherence.
    Ott C; Mahfoud F; Schmid A; Ewen S; Toennes SW; Meyer MR; Helfer AG; Maurer HH; Ditting T; Veelken R; Zivanovic I; Uder M; Böhm M; Schmieder RE
    J Hypertens; 2016 Dec; 34(12):2475-2479. PubMed ID: 27607458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial.
    Mathiassen ON; Vase H; Bech JN; Christensen KL; Buus NH; Schroeder AP; Lederballe O; Rickers H; Kampmann U; Poulsen PL; Hansen KW; Btker HE; Peters CD; Engholm M; Bertelsen JB; Lassen JF; Langfeldt S; Andersen G; Pedersen EB; Kaltoft A
    J Hypertens; 2016 Aug; 34(8):1639-47. PubMed ID: 27228432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure changes after catheter-based renal denervation are related to reductions in total peripheral resistance.
    Ewen S; Cremers B; Meyer MR; Donazzan L; Kindermann I; Ukena C; Helfer AG; Maurer HH; Laufs U; Grassi G; Böhm M; Mahfoud F
    J Hypertens; 2015 Dec; 33(12):2519-25. PubMed ID: 26485463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal denervation in moderate treatment-resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial.
    Oliveras A; Armario P; Clarà A; Sans-Atxer L; Vázquez S; Pascual J; De la Sierra A
    J Hypertens; 2016 Sep; 34(9):1863-71. PubMed ID: 27327441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
    Fadl Elmula FE; Hoffmann P; Larstorp AC; Fossum E; Brekke M; Kjeldsen SE; Gjønnæss E; Hjørnholm U; Kjaer VN; Rostrup M; Os I; Stenehjem A; Høieggen A
    Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure variability after catheter-based renal sympathetic denervation in patients with resistant hypertension.
    Ewen S; Dörr O; Ukena C; Linz D; Cremers B; Laufs U; Hamm C; Nef H; Bauer A; Mancia G; Böhm M; Mahfoud F
    J Hypertens; 2015 Dec; 33(12):2512-8. PubMed ID: 26485461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension.
    Lambert T; Gammer V; Nahler A; Blessberger H; Kammler J; Grund M; Kerschner K; Buchmayr G; Saleh K; Kypta A; Hönig S; Wichert-Schmitt B; Schwarz S; Sihorsch K; Reiter C; Steinwender C
    Int J Cardiol; 2015 Feb; 181():96-101. PubMed ID: 25497527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal denervation in comparison with intensified pharmacotherapy in true resistant hypertension: 2-year outcomes of randomized PRAGUE-15 study.
    Rosa J; Widimský P; Waldauf P; Zelinka T; Petrák O; Táborský M; Branny M; Toušek P; Čurila K; Lambert L; Bednář F; Holaj R; Štrauch B; Václavík J; Kociánová E; Nykl I; Jiravský O; Rappová G; Indra T; Krátká Z; Widimský J
    J Hypertens; 2017 May; 35(5):1093-1099. PubMed ID: 28118281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
    Ewen S; Meyer MR; Cremers B; Laufs U; Helfer AG; Linz D; Kindermann I; Ukena C; Burnier M; Wagenpfeil S; Maurer HH; Böhm M; Mahfoud F
    Clin Res Cardiol; 2015 Dec; 104(12):1097-105. PubMed ID: 26306594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The randomised Oslo study of renal denervation
    Bergland OU; Søraas CL; Larstorp ACK; Halvorsen LV; Hjørnholm U; Hoffman P; Høieggen A; Fadl Elmula FEM
    Blood Press; 2021 Feb; 30(1):41-50. PubMed ID: 33030064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of response to renal denervation for resistant arterial hypertension: a single center experience.
    Rohla M; Nahler A; Lambert T; Reiter C; Gammer V; Grund M; Blessberger H; Kammler J; Kypta A; Saleh K; Huber K; Steinwender C; Weiss TW
    J Hypertens; 2016 Jan; 34(1):123-9. PubMed ID: 26556567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure.
    Fadl Elmula FE; Hoffmann P; Fossum E; Brekke M; Gjønnæss E; Hjørnholm U; Kjær VN; Rostrup M; Kjeldsen SE; Os I; Stenehjem AE; Høieggen A
    Hypertension; 2013 Sep; 62(3):526-32. PubMed ID: 23836798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of renal denervation on tissue Na
    Ott C; Kopp C; Dahlmann A; Schmid A; Linz P; Cavallaro A; Hammon M; Ditting T; Veelken R; Uder M; Titze J; Schmieder RE
    Clin Res Cardiol; 2018 Jan; 107(1):42-48. PubMed ID: 28845508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Toennes SW; Ewen S; Ditting T; Veelken R; Ukena C; Uder M; Böhm M; Schmieder RE
    J Hypertens; 2015 Jun; 33(6):1261-6. PubMed ID: 25923731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Medication Adherence on the Effect of Renal Denervation: The SYMPATHY Trial.
    de Jager RL; de Beus E; Beeftink MM; Sanders MF; Vonken EJ; Voskuil M; van Maarseveen EM; Bots ML; Blankestijn PJ;
    Hypertension; 2017 Apr; 69(4):678-684. PubMed ID: 28264922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal denervation for mild-moderate treatment-resistant hypertension : A timely intervention?
    Chen S; Kiuchi MG; Schmidt B; Hoye NA; Acou WJ; Liu S; Chun KRJ; Pürerfellner H
    Herz; 2019 Aug; 44(5):412-418. PubMed ID: 29255910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of pseudo-resistance on the effect of renal denervation on 24-hour ambulatory blood pressure levels.
    Lambert T; Nahler A; Reiter C; Gammer V; Blessberger H; Kammler J; Grund M; Saleh K; Schwarz S; Steinwender C
    Catheter Cardiovasc Interv; 2015 Sep; 86(3):E126-30. PubMed ID: 26033366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular and renal hemodynamic changes after renal denervation.
    Ott C; Janka R; Schmid A; Titze S; Ditting T; Sobotka PA; Veelken R; Uder M; Schmieder RE
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1195-201. PubMed ID: 23559677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to Antihypertensive Medication in Treatment-Resistant Hypertension Undergoing Renal Denervation.
    Schmieder RE; Ott C; Schmid A; Friedrich S; Kistner I; Ditting T; Veelken R; Uder M; Toennes SW
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.